Rank | Gene Set | Z-score |
---|---|---|
1 | nuclear pore complex assembly (GO:0051292) | 4.64371913 |
2 | histone H3-K36 demethylation (GO:0070544) | 4.39602560 |
3 | mitotic sister chromatid cohesion (GO:0007064) | 3.99240385 |
4 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 3.89935242 |
5 | nuclear pore organization (GO:0006999) | 3.89404707 |
6 | regulation of nucleobase-containing compound transport (GO:0032239) | 3.88787193 |
7 | regulation of histone H3-K9 methylation (GO:0051570) | 3.84793996 |
8 | mitotic chromosome condensation (GO:0007076) | 3.84117589 |
9 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.83290396 |
10 | peptidyl-threonine dephosphorylation (GO:0035970) | 3.78493337 |
11 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.76205243 |
12 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 3.69172657 |
13 | DNA ligation (GO:0006266) | 3.63382839 |
14 | embryonic process involved in female pregnancy (GO:0060136) | 3.61998887 |
15 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 3.55960030 |
16 | genitalia morphogenesis (GO:0035112) | 3.55902952 |
17 | regulation of DNA endoreduplication (GO:0032875) | 3.46101401 |
18 | regulation of stem cell maintenance (GO:2000036) | 3.44949907 |
19 | definitive hemopoiesis (GO:0060216) | 3.44309463 |
20 | pore complex assembly (GO:0046931) | 3.44015751 |
21 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.41289016 |
22 | adherens junction assembly (GO:0034333) | 3.38703814 |
23 | histone H3-K4 methylation (GO:0051568) | 3.36211393 |
24 | focal adhesion assembly (GO:0048041) | 3.35508659 |
25 | cell-substrate adherens junction assembly (GO:0007045) | 3.35508659 |
26 | histone lysine demethylation (GO:0070076) | 3.35059244 |
27 | DNA replication initiation (GO:0006270) | 3.30294280 |
28 | glucocorticoid receptor signaling pathway (GO:0042921) | 3.29154794 |
29 | histone H3-K4 trimethylation (GO:0080182) | 3.28837195 |
30 | regulation of chromatin binding (GO:0035561) | 3.27686759 |
31 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.25707810 |
32 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.25362043 |
33 | negative regulation of histone methylation (GO:0031061) | 3.25146225 |
34 | interkinetic nuclear migration (GO:0022027) | 3.20839592 |
35 | histone demethylation (GO:0016577) | 3.18997287 |
36 | endothelium development (GO:0003158) | 3.17906556 |
37 | pattern specification involved in kidney development (GO:0061004) | 3.16585541 |
38 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 3.16002347 |
39 | histone H3-K9 demethylation (GO:0033169) | 3.15963431 |
40 | cellular response to epidermal growth factor stimulus (GO:0071364) | 3.15846737 |
41 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.15106785 |
42 | nephron tubule formation (GO:0072079) | 3.13585888 |
43 | regulation of histone H3-K4 methylation (GO:0051569) | 3.09312806 |
44 | response to folic acid (GO:0051593) | 3.08282855 |
45 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 3.07346529 |
46 | chromatin assembly (GO:0031497) | 3.06836591 |
47 | negative regulation of RNA splicing (GO:0033119) | 3.06250064 |
48 | kinetochore organization (GO:0051383) | 3.02609112 |
49 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 3.02431337 |
50 | DNA unwinding involved in DNA replication (GO:0006268) | 3.02186976 |
51 | corticosteroid receptor signaling pathway (GO:0031958) | 3.00596369 |
52 | DNA duplex unwinding (GO:0032508) | 2.98775573 |
53 | activation of Rac GTPase activity (GO:0032863) | 2.96982165 |
54 | urogenital system development (GO:0001655) | 2.96222381 |
55 | negative regulation of granulocyte differentiation (GO:0030853) | 2.95904460 |
56 | DNA geometric change (GO:0032392) | 2.95425072 |
57 | stress granule assembly (GO:0034063) | 2.95083417 |
58 | pre-miRNA processing (GO:0031054) | 2.94656365 |
59 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.93998334 |
60 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.93427190 |
61 | viral transcription (GO:0019083) | 2.92795065 |
62 | response to epidermal growth factor (GO:0070849) | 2.91845015 |
63 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.91422727 |
64 | mitotic recombination (GO:0006312) | 2.90608150 |
65 | telomere maintenance via recombination (GO:0000722) | 2.90486360 |
66 | Golgi transport vesicle coating (GO:0048200) | 2.89381357 |
67 | COPI coating of Golgi vesicle (GO:0048205) | 2.89381357 |
68 | dosage compensation (GO:0007549) | 2.89283939 |
69 | positive regulation of hormone metabolic process (GO:0032352) | 2.88572145 |
70 | peptidyl-lysine dimethylation (GO:0018027) | 2.87752031 |
71 | sister chromatid cohesion (GO:0007062) | 2.87751311 |
72 | negative regulation of mRNA processing (GO:0050686) | 2.86974600 |
73 | regulation of cholesterol homeostasis (GO:2000188) | 2.83469854 |
74 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 2.80922030 |
75 | translational termination (GO:0006415) | 2.79895798 |
76 | heterochromatin organization (GO:0070828) | 2.77579262 |
77 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.77490638 |
78 | megakaryocyte development (GO:0035855) | 2.76662284 |
79 | DNA dealkylation (GO:0035510) | 2.76550688 |
80 | protein dealkylation (GO:0008214) | 2.76480223 |
81 | protein demethylation (GO:0006482) | 2.76480223 |
82 | trophectodermal cell differentiation (GO:0001829) | 2.76271400 |
83 | lymphoid progenitor cell differentiation (GO:0002320) | 2.75011599 |
84 | peptidyl-lysine trimethylation (GO:0018023) | 2.74725593 |
85 | regulation of histone methylation (GO:0031060) | 2.74710260 |
86 | histone H4-K12 acetylation (GO:0043983) | 2.74148791 |
87 | protein localization to kinetochore (GO:0034501) | 2.74100375 |
88 | apoptotic process involved in morphogenesis (GO:0060561) | 2.73650446 |
89 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.72321610 |
90 | histone H4-K16 acetylation (GO:0043984) | 2.71888068 |
91 | embryonic camera-type eye morphogenesis (GO:0048596) | 2.71788174 |
92 | cell-substrate junction assembly (GO:0007044) | 2.70667659 |
93 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.68550423 |
94 | determination of adult lifespan (GO:0008340) | 2.67080643 |
95 | protein export from nucleus (GO:0006611) | 2.66863120 |
96 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.66627602 |
97 | negative regulation of myotube differentiation (GO:0010832) | 2.65916403 |
98 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.65161289 |
99 | mannose metabolic process (GO:0006013) | 2.64322348 |
100 | regulation of histone H3-K27 methylation (GO:0061085) | 2.63642581 |
101 | nucleosome disassembly (GO:0006337) | 2.62850916 |
102 | protein-DNA complex disassembly (GO:0032986) | 2.62850916 |
103 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.62455207 |
104 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.61897361 |
105 | chromosome condensation (GO:0030261) | 2.61376765 |
106 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 2.60739549 |
107 | embryonic eye morphogenesis (GO:0048048) | 2.60657196 |
108 | mRNA splice site selection (GO:0006376) | 2.60139808 |
109 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.59362459 |
110 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.59172164 |
111 | response to laminar fluid shear stress (GO:0034616) | 2.59049194 |
112 | histone lysine methylation (GO:0034968) | 2.59048461 |
113 | kinetochore assembly (GO:0051382) | 2.58954095 |
114 | embryonic hemopoiesis (GO:0035162) | 2.58272896 |
115 | negative regulation of mRNA metabolic process (GO:1903312) | 2.57345203 |
116 | positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145) | 2.56866724 |
117 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.56022577 |
118 | negative regulation of cell size (GO:0045792) | 2.55723547 |
119 | regulation of mitotic spindle organization (GO:0060236) | 2.55697779 |
120 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.55584282 |
121 | intra-S DNA damage checkpoint (GO:0031573) | 2.55573531 |
122 | histone mRNA catabolic process (GO:0071044) | 2.55504047 |
123 | negative regulation of metanephros development (GO:0072217) | 2.54200327 |
124 | RNA stabilization (GO:0043489) | 2.53686101 |
125 | mRNA stabilization (GO:0048255) | 2.53686101 |
126 | regulation of RNA export from nucleus (GO:0046831) | 2.52640782 |
127 | protein localization to chromosome, centromeric region (GO:0071459) | 2.52414289 |
128 | histone H3 acetylation (GO:0043966) | 2.52129202 |
129 | DNA strand elongation (GO:0022616) | 2.52115321 |
130 | mesenchymal to epithelial transition (GO:0060231) | 2.51391012 |
131 | negative regulation of viral release from host cell (GO:1902187) | 2.50450740 |
132 | DNA conformation change (GO:0071103) | 2.48983891 |
133 | positive regulation of gene expression, epigenetic (GO:0045815) | 2.48647646 |
134 | positive regulation of histone deacetylation (GO:0031065) | 2.48630515 |
135 | maternal placenta development (GO:0001893) | 2.47462173 |
136 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.47152652 |
137 | regulation of DNA damage checkpoint (GO:2000001) | 2.47055150 |
138 | positive regulation of cell cycle checkpoint (GO:1901978) | 2.47041529 |
139 | histone H3-K9 methylation (GO:0051567) | 2.46906970 |
140 | histone H4-K5 acetylation (GO:0043981) | 2.46831923 |
141 | histone H4-K8 acetylation (GO:0043982) | 2.46831923 |
142 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.46720539 |
143 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.46720539 |
144 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.46720539 |
145 | peptidyl-threonine phosphorylation (GO:0018107) | 2.46531274 |
146 | mitotic nuclear envelope disassembly (GO:0007077) | 2.45927767 |
147 | histone methylation (GO:0016571) | 2.45753989 |
148 | positive regulation of cell cycle G2/M phase transition (GO:1902751) | 2.45543502 |
149 | positive regulation of G2/M transition of mitotic cell cycle (GO:0010971) | 2.45543502 |
150 | sister chromatid segregation (GO:0000819) | 2.45485131 |
151 | negative regulation of fatty acid transport (GO:2000192) | 2.44828497 |
152 | nuclear envelope disassembly (GO:0051081) | 2.43741546 |
153 | membrane disassembly (GO:0030397) | 2.43741546 |
154 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.43702100 |
155 | negative regulation of chromatin modification (GO:1903309) | 2.43516156 |
156 | peptidyl-threonine modification (GO:0018210) | 2.43277573 |
157 | histone deubiquitination (GO:0016578) | 2.43247381 |
158 | regulation of gene silencing (GO:0060968) | 2.43234259 |
159 | negative regulation of DNA repair (GO:0045738) | 2.42605918 |
160 | facial nerve structural organization (GO:0021612) | 2.42187179 |
161 | negative regulation of histone modification (GO:0031057) | 2.41640885 |
162 | DNA topological change (GO:0006265) | 2.41286461 |
163 | nephron epithelium development (GO:0072009) | 2.40300319 |
164 | telomere maintenance via telomere lengthening (GO:0010833) | 2.40080814 |
165 | mesonephros development (GO:0001823) | 2.39982435 |
166 | regulation of mRNA stability (GO:0043488) | 2.39489331 |
167 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.38632680 |
168 | histone H4 deacetylation (GO:0070933) | 2.38592291 |
169 | regulation of translational fidelity (GO:0006450) | 2.34631312 |
170 | mitotic sister chromatid segregation (GO:0000070) | 2.34339228 |
171 | NLS-bearing protein import into nucleus (GO:0006607) | 2.32103801 |
172 | nuclear envelope organization (GO:0006998) | 2.31750815 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 4.38859099 |
2 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.99733640 |
3 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.46995690 |
4 | * MYC_22102868_ChIP-Seq_BL_Human | 3.16591558 |
5 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.11603588 |
6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.08739987 |
7 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.78229721 |
8 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.67975772 |
9 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.56348308 |
10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.55551526 |
11 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.55317878 |
12 | * SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.39994106 |
13 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.33494798 |
14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.27265177 |
15 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 2.17120950 |
16 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.08460462 |
17 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.08336227 |
18 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.06331764 |
19 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.05955369 |
20 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.04577578 |
21 | E2F7_22180533_ChIP-Seq_HELA_Human | 10.6060390 |
22 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.99036482 |
23 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.98719286 |
24 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.98456634 |
25 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.95331566 |
26 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.95331566 |
27 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.95331566 |
28 | MYB_26560356_Chip-Seq_TH1_Human | 1.94259584 |
29 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.93244032 |
30 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.87696000 |
31 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.86494777 |
32 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.85041630 |
33 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.82953983 |
34 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.82840356 |
35 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.76122245 |
36 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.76106002 |
37 | MAF_26560356_Chip-Seq_TH1_Human | 1.74846836 |
38 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.72373280 |
39 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.70217603 |
40 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69021291 |
41 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.68931660 |
42 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.66895324 |
43 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.65033317 |
44 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.64916935 |
45 | UTX_26944678_Chip-Seq_JUKART_Human | 1.64128639 |
46 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.60734324 |
47 | KDM2B_26808549_Chip-Seq_K562_Human | 1.59183963 |
48 | MYB_26560356_Chip-Seq_TH2_Human | 1.57839884 |
49 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.57415623 |
50 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.56949101 |
51 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.52762847 |
52 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.52488641 |
53 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.51218906 |
54 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.50383924 |
55 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.49564830 |
56 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.48488462 |
57 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.48338600 |
58 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.48220679 |
59 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47757811 |
60 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.47594385 |
61 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.47014246 |
62 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.46879413 |
63 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.46694821 |
64 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.43873626 |
65 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.43792111 |
66 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.43670386 |
67 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.43025125 |
68 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.42417856 |
69 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.40182728 |
70 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.40050615 |
71 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.38926564 |
72 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.35462265 |
73 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.35031460 |
74 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.34531203 |
75 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.34043330 |
76 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.33415773 |
77 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.33124693 |
78 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.32452691 |
79 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.31613832 |
80 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.31247779 |
81 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.31049538 |
82 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.28865776 |
83 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.27762610 |
84 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.27113838 |
85 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.26506384 |
86 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.25076760 |
87 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.24821970 |
88 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.24134948 |
89 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.23949924 |
90 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.23040668 |
91 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.22990092 |
92 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.22669744 |
93 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.21107225 |
94 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.18533862 |
95 | * TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.18031765 |
96 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.16785591 |
97 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.16736475 |
98 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.15038971 |
99 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.14316483 |
100 | SPI1_23127762_ChIP-Seq_K562_Human | 1.14199746 |
101 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.13500963 |
102 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.13336781 |
103 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.13211891 |
104 | ATF3_27146783_Chip-Seq_COLON_Human | 1.12757478 |
105 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.12519687 |
106 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.12215305 |
107 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11957722 |
108 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10857552 |
109 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.10584737 |
110 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.09962408 |
111 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.09923769 |
112 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.09525895 |
113 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.08354443 |
114 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.07958585 |
115 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.07162025 |
116 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.06991751 |
117 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.06774021 |
118 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.06258297 |
119 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.05339095 |
120 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.04057543 |
121 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.03658566 |
122 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.02652274 |
123 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.01748478 |
124 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.01642389 |
125 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 1.01335509 |
126 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.01196184 |
127 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.01073209 |
128 | MAF_26560356_Chip-Seq_TH2_Human | 1.00349623 |
129 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.99772596 |
130 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.99389522 |
131 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.98539905 |
132 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.98471569 |
133 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.98332091 |
134 | * NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.97804598 |
135 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.97717006 |
136 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.97694783 |
137 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.96729544 |
138 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.94177945 |
139 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.93657625 |
140 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.92425500 |
141 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.92216800 |
142 | * SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.91212092 |
143 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.86928032 |
144 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.86176877 |
145 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.84848713 |
146 | GATA1_22025678_ChIP-Seq_K562_Human | 0.82968296 |
147 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.80201812 |
148 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.79546004 |
149 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.78562204 |
150 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.77185768 |
151 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.75853101 |
152 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.74763238 |
153 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.74677167 |
154 | * ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.73499643 |
155 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.73349688 |
156 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.72871819 |
157 | * TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.71890308 |
158 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.71414707 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0009379_abnormal_foot_pigmentation | 3.96807783 |
2 | MP0003705_abnormal_hypodermis_morpholog | 3.65465045 |
3 | MP0005174_abnormal_tail_pigmentation | 3.44728497 |
4 | MP0005409_darkened_coat_color | 3.12033844 |
5 | MP0008057_abnormal_DNA_replication | 3.09767190 |
6 | MP0003303_peritoneal_inflammation | 3.03854068 |
7 | MP0003136_yellow_coat_color | 2.86319258 |
8 | MP0002396_abnormal_hematopoietic_system | 2.77955139 |
9 | MP0005451_abnormal_body_composition | 2.60902132 |
10 | MP0010094_abnormal_chromosome_stability | 2.53494668 |
11 | MP0004264_abnormal_extraembryonic_tissu | 2.41472327 |
12 | MP0000015_abnormal_ear_pigmentation | 2.39361792 |
13 | MP0004185_abnormal_adipocyte_glucose | 2.35267933 |
14 | MP0003724_increased_susceptibility_to | 2.21101074 |
15 | MP0006292_abnormal_olfactory_placode | 2.19785666 |
16 | MP0001188_hyperpigmentation | 2.17358893 |
17 | MP0003566_abnormal_cell_adhesion | 2.12435055 |
18 | MP0010234_abnormal_vibrissa_follicle | 2.09604427 |
19 | MP0004808_abnormal_hematopoietic_stem | 2.07724926 |
20 | MP0002166_altered_tumor_susceptibility | 2.02829166 |
21 | MP0002095_abnormal_skin_pigmentation | 2.00150046 |
22 | MP0003763_abnormal_thymus_physiology | 1.98265928 |
23 | MP0001730_embryonic_growth_arrest | 1.94564796 |
24 | MP0003111_abnormal_nucleus_morphology | 1.93880951 |
25 | MP0004381_abnormal_hair_follicle | 1.93633601 |
26 | MP0000490_abnormal_crypts_of | 1.92378352 |
27 | MP0000569_abnormal_digit_pigmentation | 1.87738145 |
28 | MP0005397_hematopoietic_system_phenotyp | 1.87065726 |
29 | MP0001545_abnormal_hematopoietic_system | 1.87065726 |
30 | MP0005075_abnormal_melanosome_morpholog | 1.85613836 |
31 | MP0004233_abnormal_muscle_weight | 1.83332423 |
32 | MP0008007_abnormal_cellular_replicative | 1.80720773 |
33 | MP0003828_pulmonary_edema | 1.79102255 |
34 | MP0008058_abnormal_DNA_repair | 1.67579604 |
35 | MP0001849_ear_inflammation | 1.67162582 |
36 | MP0003091_abnormal_cell_migration | 1.67137103 |
37 | MP0003077_abnormal_cell_cycle | 1.64975597 |
38 | MP0000537_abnormal_urethra_morphology | 1.58699884 |
39 | MP0005076_abnormal_cell_differentiation | 1.55795137 |
40 | MP0009672_abnormal_birth_weight | 1.54489130 |
41 | MP0001915_intracranial_hemorrhage | 1.52663566 |
42 | MP0008260_abnormal_autophagy | 1.51421494 |
43 | MP0009278_abnormal_bone_marrow | 1.51111047 |
44 | MP0002249_abnormal_larynx_morphology | 1.50537583 |
45 | MP0010307_abnormal_tumor_latency | 1.47000076 |
46 | MP0002075_abnormal_coat/hair_pigmentati | 1.46279683 |
47 | MP0002006_tumorigenesis | 1.46113852 |
48 | MP0002796_impaired_skin_barrier | 1.46000670 |
49 | MP0002177_abnormal_outer_ear | 1.45398938 |
50 | MP0002089_abnormal_postnatal_growth/wei | 1.40048378 |
51 | MP0003123_paternal_imprinting | 1.38641876 |
52 | MP0003453_abnormal_keratinocyte_physiol | 1.38166610 |
53 | MP0003868_abnormal_feces_composition | 1.37839899 |
54 | MP0010352_gastrointestinal_tract_polyps | 1.37021550 |
55 | * MP0002398_abnormal_bone_marrow | 1.35718713 |
56 | MP0000003_abnormal_adipose_tissue | 1.32846841 |
57 | MP0003693_abnormal_embryo_hatching | 1.32094734 |
58 | MP0005621_abnormal_cell_physiology | 1.31461724 |
59 | MP0003786_premature_aging | 1.31104500 |
60 | MP0000371_diluted_coat_color | 1.30874598 |
61 | MP0004957_abnormal_blastocyst_morpholog | 1.30012295 |
62 | MP0003115_abnormal_respiratory_system | 1.28610536 |
63 | MP0000049_abnormal_middle_ear | 1.28074089 |
64 | MP0000703_abnormal_thymus_morphology | 1.27694860 |
65 | MP0001835_abnormal_antigen_presentation | 1.27592265 |
66 | MP0001348_abnormal_lacrimal_gland | 1.27504394 |
67 | MP0001800_abnormal_humoral_immune | 1.26009426 |
68 | MP0005666_abnormal_adipose_tissue | 1.24630758 |
69 | MP0001697_abnormal_embryo_size | 1.21545542 |
70 | MP0000733_abnormal_muscle_development | 1.19449771 |
71 | MP0009333_abnormal_splenocyte_physiolog | 1.17645582 |
72 | MP0001986_abnormal_taste_sensitivity | 1.17090251 |
73 | MP0010630_abnormal_cardiac_muscle | 1.16857390 |
74 | MP0005671_abnormal_response_to | 1.16041874 |
75 | * MP0000689_abnormal_spleen_morphology | 1.15883900 |
76 | MP0005375_adipose_tissue_phenotype | 1.14593733 |
77 | MP0002009_preneoplasia | 1.14512059 |
78 | MP0000350_abnormal_cell_proliferation | 1.13893519 |
79 | MP0000685_abnormal_immune_system | 1.13718681 |
80 | MP0005501_abnormal_skin_physiology | 1.12454226 |
81 | MP0000465_gastrointestinal_hemorrhage | 1.12413392 |
82 | MP0004858_abnormal_nervous_system | 1.11311800 |
83 | MP0002933_joint_inflammation | 1.08306245 |
84 | * MP0002722_abnormal_immune_system | 1.07593860 |
85 | MP0002060_abnormal_skin_morphology | 1.02378964 |
86 | MP0003172_abnormal_lysosome_physiology | 1.01727209 |
87 | MP0009703_decreased_birth_body | 0.99634624 |
88 | MP0002019_abnormal_tumor_incidence | 0.99397085 |
89 | MP0004197_abnormal_fetal_growth/weight/ | 0.99158845 |
90 | MP0004947_skin_inflammation | 0.99080172 |
91 | MP0005384_cellular_phenotype | 0.97281448 |
92 | MP0001661_extended_life_span | 0.96998935 |
93 | MP0000428_abnormal_craniofacial_morphol | 0.96992794 |
94 | * MP0000716_abnormal_immune_system | 0.94741579 |
95 | MP0001293_anophthalmia | 0.94617520 |
96 | MP0002102_abnormal_ear_morphology | 0.94589552 |
97 | MP0001873_stomach_inflammation | 0.93664253 |
98 | MP0008961_abnormal_basal_metabolism | 0.92550703 |
99 | MP0002420_abnormal_adaptive_immunity | 0.92195430 |
100 | MP0003300_gastrointestinal_ulcer | 0.92137758 |
101 | MP0000313_abnormal_cell_death | 0.91769255 |
102 | MP0005623_abnormal_meninges_morphology | 0.91558814 |
103 | MP0002085_abnormal_embryonic_tissue | 0.91032916 |
104 | MP0002925_abnormal_cardiovascular_devel | 0.90978080 |
105 | MP0005257_abnormal_intraocular_pressure | 0.90083791 |
106 | MP0001186_pigmentation_phenotype | 0.89786452 |
107 | MP0000432_abnormal_head_morphology | 0.89677466 |
108 | MP0002452_abnormal_antigen_presenting | 0.89354968 |
109 | MP0001819_abnormal_immune_cell | 0.89247625 |
110 | MP0005380_embryogenesis_phenotype | 0.88862641 |
111 | MP0001672_abnormal_embryogenesis/_devel | 0.88862641 |
112 | MP0002210_abnormal_sex_determination | 0.88637500 |
113 | MP0000858_altered_metastatic_potential | 0.88170496 |
114 | MP0000372_irregular_coat_pigmentation | 0.87867491 |
115 | MP0002084_abnormal_developmental_patter | 0.87471336 |
116 | MP0010155_abnormal_intestine_physiology | 0.86819729 |
117 | MP0003935_abnormal_craniofacial_develop | 0.85955144 |
118 | * MP0002429_abnormal_blood_cell | 0.85356466 |
119 | MP0000681_abnormal_thyroid_gland | 0.85086555 |
120 | MP0002098_abnormal_vibrissa_morphology | 0.84866267 |
121 | MP0002723_abnormal_immune_serum | 0.83800871 |
122 | MP0001346_abnormal_lacrimal_gland | 0.83733669 |
123 | MP0003436_decreased_susceptibility_to | 0.83588077 |
124 | MP0002086_abnormal_extraembryonic_tissu | 0.83391744 |
125 | MP0000377_abnormal_hair_follicle | 0.83183788 |
126 | MP0003984_embryonic_growth_retardation | 0.83148428 |
127 | MP0002088_abnormal_embryonic_growth/wei | 0.82955080 |
128 | MP0001216_abnormal_epidermal_layer | 0.81215036 |
129 | MP0003191_abnormal_cellular_cholesterol | 0.80342367 |
130 | MP0008877_abnormal_DNA_methylation | 0.78071629 |
131 | MP0003221_abnormal_cardiomyocyte_apopto | 0.77990717 |
132 | MP0000477_abnormal_intestine_morphology | 0.77734132 |
133 | MP0002877_abnormal_melanocyte_morpholog | 0.76900846 |
134 | MP0003941_abnormal_skin_development | 0.76593736 |
135 | MP0000678_abnormal_parathyroid_gland | 0.76572603 |
136 | MP0009931_abnormal_skin_appearance | 0.75351116 |
137 | MP0003567_abnormal_fetal_cardiomyocyte | 0.73868610 |
138 | MP0003938_abnormal_ear_development | 0.73213790 |
139 | MP0004087_abnormal_muscle_fiber | 0.73030952 |
140 | MP0002092_abnormal_eye_morphology | 0.72332663 |
141 | MP0009115_abnormal_fat_cell | 0.72002202 |
142 | MP0008995_early_reproductive_senescence | 0.71949242 |
143 | MP0002970_abnormal_white_adipose | 0.71822546 |
144 | MP0008932_abnormal_embryonic_tissue | 0.71748276 |
145 | MP0000566_synostosis | 0.71598424 |
146 | MP0003942_abnormal_urinary_system | 0.71126700 |
147 | MP0005058_abnormal_lysosome_morphology | 0.70829032 |
148 | MP0003890_abnormal_embryonic-extraembry | 0.70714656 |
149 | MP0010030_abnormal_orbit_morphology | 0.69939431 |
150 | MP0003943_abnormal_hepatobiliary_system | 0.69403100 |
151 | MP0005025_abnormal_response_to | 0.69153206 |
152 | MP0005000_abnormal_immune_tolerance | 0.68220279 |
153 | MP0002080_prenatal_lethality | 0.67436794 |
154 | MP0003646_muscle_fatigue | 0.67176351 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Reduced antithrombin III activity (HP:0001976) | 4.45899785 |
2 | Abnormality of the fingertips (HP:0001211) | 3.77114168 |
3 | Type I transferrin isoform profile (HP:0003642) | 3.59941447 |
4 | Hyperacusis (HP:0010780) | 3.33352442 |
5 | Thyroid-stimulating hormone excess (HP:0002925) | 3.28459870 |
6 | Broad face (HP:0000283) | 3.19646596 |
7 | Chromsome breakage (HP:0040012) | 3.00661423 |
8 | Flat acetabular roof (HP:0003180) | 3.00410658 |
9 | Volvulus (HP:0002580) | 2.90938854 |
10 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.90454369 |
11 | Asymmetry of the thorax (HP:0001555) | 2.86337468 |
12 | Acute lymphatic leukemia (HP:0006721) | 2.84024186 |
13 | Ankle contracture (HP:0006466) | 2.73777162 |
14 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.73552090 |
15 | Acute myeloid leukemia (HP:0004808) | 2.72951820 |
16 | Dislocated radial head (HP:0003083) | 2.68002152 |
17 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.65594695 |
18 | Sparse lateral eyebrow (HP:0005338) | 2.62297998 |
19 | Long eyelashes (HP:0000527) | 2.57591328 |
20 | Dysmetric saccades (HP:0000641) | 2.53457704 |
21 | Abnormality of the radial head (HP:0003995) | 2.42921815 |
22 | Clubbing of toes (HP:0100760) | 2.41523440 |
23 | Urethral obstruction (HP:0000796) | 2.40541441 |
24 | Narrow palate (HP:0000189) | 2.40535281 |
25 | Obstructive sleep apnea (HP:0002870) | 2.37541587 |
26 | Deep venous thrombosis (HP:0002625) | 2.35371925 |
27 | Medulloblastoma (HP:0002885) | 2.34970454 |
28 | Ulnar bowing (HP:0003031) | 2.34414903 |
29 | Vertebral arch anomaly (HP:0008438) | 2.33852191 |
30 | Smooth philtrum (HP:0000319) | 2.30039909 |
31 | Attenuation of retinal blood vessels (HP:0007843) | 2.29452163 |
32 | Abnormality of chromosome stability (HP:0003220) | 2.28420636 |
33 | Ankyloglossia (HP:0010296) | 2.27096815 |
34 | Broad palm (HP:0001169) | 2.26702514 |
35 | Subacute progressive viral hepatitis (HP:0006572) | 2.26475161 |
36 | Ectopic kidney (HP:0000086) | 2.25827169 |
37 | Severe visual impairment (HP:0001141) | 2.21675264 |
38 | Abnormal protein glycosylation (HP:0012346) | 2.18692154 |
39 | Abnormal glycosylation (HP:0012345) | 2.18692154 |
40 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.18692154 |
41 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.18692154 |
42 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.18608094 |
43 | Depressed nasal tip (HP:0000437) | 2.16736184 |
44 | Lip pit (HP:0100267) | 2.16686132 |
45 | Deep philtrum (HP:0002002) | 2.15532966 |
46 | Macroorchidism (HP:0000053) | 2.14588991 |
47 | Prominent nose (HP:0000448) | 2.14174872 |
48 | Rhabdomyosarcoma (HP:0002859) | 2.11631988 |
49 | Intestinal fistula (HP:0100819) | 2.10818244 |
50 | Pendular nystagmus (HP:0012043) | 2.10669684 |
51 | Prolonged bleeding time (HP:0003010) | 2.10263503 |
52 | Myelodysplasia (HP:0002863) | 2.08682171 |
53 | Disproportionate tall stature (HP:0001519) | 2.07721985 |
54 | Absent frontal sinuses (HP:0002688) | 2.07319720 |
55 | Hypothermia (HP:0002045) | 2.07149099 |
56 | Persistence of primary teeth (HP:0006335) | 2.06238506 |
57 | Advanced eruption of teeth (HP:0006288) | 2.06080454 |
58 | Meckel diverticulum (HP:0002245) | 2.05667128 |
59 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 2.05475949 |
60 | Deviation of the thumb (HP:0009603) | 2.05456044 |
61 | Abnormality of oral frenula (HP:0000190) | 2.04756862 |
62 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.04681028 |
63 | Short 4th metacarpal (HP:0010044) | 2.04681028 |
64 | Supernumerary ribs (HP:0005815) | 2.04405468 |
65 | Abnormality of the ileum (HP:0001549) | 2.04186775 |
66 | Neonatal hypoglycemia (HP:0001998) | 2.03505217 |
67 | Abnormality of the columella (HP:0009929) | 2.03385663 |
68 | Anal stenosis (HP:0002025) | 2.02698219 |
69 | Neoplasm of the oral cavity (HP:0100649) | 2.02527477 |
70 | Septate vagina (HP:0001153) | 2.01720130 |
71 | Reticulocytopenia (HP:0001896) | 2.01017878 |
72 | Long palpebral fissure (HP:0000637) | 2.00776098 |
73 | Agammaglobulinemia (HP:0004432) | 1.99284113 |
74 | Flat occiput (HP:0005469) | 1.99115965 |
75 | Abnormal foot bone ossification (HP:0010675) | 1.98488478 |
76 | Small hand (HP:0200055) | 1.97598688 |
77 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.97555003 |
78 | Supernumerary spleens (HP:0009799) | 1.97097391 |
79 | Trigonocephaly (HP:0000243) | 1.92185057 |
80 | Abnormality of the preputium (HP:0100587) | 1.91691742 |
81 | Truncal obesity (HP:0001956) | 1.91382154 |
82 | Abnormal ossification of hand bones (HP:0005921) | 1.91118166 |
83 | Germ cell neoplasia (HP:0100728) | 1.90244061 |
84 | Amaurosis fugax (HP:0100576) | 1.89980160 |
85 | Heterotopia (HP:0002282) | 1.89972094 |
86 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.89871682 |
87 | Abnormality of the humeroradial joint (HP:0100744) | 1.89547215 |
88 | Neoplasm of striated muscle (HP:0009728) | 1.89321360 |
89 | Cellulitis (HP:0100658) | 1.89145554 |
90 | Overlapping toe (HP:0001845) | 1.89016567 |
91 | Panhypogammaglobulinemia (HP:0003139) | 1.88957227 |
92 | Supernumerary bones of the axial skeleton (HP:0009144) | 1.87799496 |
93 | Spinal cord lesions (HP:0100561) | 1.87682047 |
94 | Syringomyelia (HP:0003396) | 1.87682047 |
95 | Sandal gap (HP:0001852) | 1.85597399 |
96 | Abnormality of the carotid arteries (HP:0005344) | 1.85467001 |
97 | Obsessive-compulsive behavior (HP:0000722) | 1.83189583 |
98 | Laryngomalacia (HP:0001601) | 1.82688141 |
99 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.82038112 |
100 | Recurrent viral infections (HP:0004429) | 1.81746129 |
101 | Colitis (HP:0002583) | 1.81316219 |
102 | Absent thumb (HP:0009777) | 1.80990860 |
103 | Microcytic anemia (HP:0001935) | 1.80717340 |
104 | Progressive external ophthalmoplegia (HP:0000590) | 1.79421167 |
105 | Bronchomalacia (HP:0002780) | 1.79385420 |
106 | Thoracic kyphosis (HP:0002942) | 1.79153293 |
107 | Abnormality of carpal bone ossification (HP:0006257) | 1.78802614 |
108 | Increased connective tissue (HP:0009025) | 1.78730249 |
109 | Increased nuchal translucency (HP:0010880) | 1.78384032 |
110 | Embryonal renal neoplasm (HP:0011794) | 1.78161893 |
111 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.77813122 |
112 | Gastrointestinal carcinoma (HP:0002672) | 1.77813122 |
113 | Abnormality of the phalanges of the hallux (HP:0010057) | 1.76283555 |
114 | Distal lower limb amyotrophy (HP:0008944) | 1.76008243 |
115 | Hemorrhage of the eye (HP:0011885) | 1.75228665 |
116 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.75058207 |
117 | Pointed chin (HP:0000307) | 1.74399490 |
118 | Deep palmar crease (HP:0006191) | 1.74309140 |
119 | Limited elbow extension (HP:0001377) | 1.73525535 |
120 | Viral hepatitis (HP:0006562) | 1.73197714 |
121 | Skin tags (HP:0010609) | 1.72874659 |
122 | Basal cell carcinoma (HP:0002671) | 1.72404337 |
123 | Selective tooth agenesis (HP:0001592) | 1.71635678 |
124 | Midline defect of the nose (HP:0004122) | 1.71288930 |
125 | Abnormality of the nasal septum (HP:0000419) | 1.71178698 |
126 | Mitral valve prolapse (HP:0001634) | 1.70678797 |
127 | Leiomyosarcoma (HP:0100243) | 1.70490935 |
128 | Uterine leiomyosarcoma (HP:0002891) | 1.70490935 |
129 | Hypochromic anemia (HP:0001931) | 1.70180135 |
130 | Cerebral aneurysm (HP:0004944) | 1.69900132 |
131 | Recurrent fungal infections (HP:0002841) | 1.69497979 |
132 | Arnold-Chiari malformation (HP:0002308) | 1.69470783 |
133 | Shallow orbits (HP:0000586) | 1.69363601 |
134 | Meningitis (HP:0001287) | 1.69049992 |
135 | Self-mutilation (HP:0000742) | 1.68648444 |
136 | Abnormal number of incisors (HP:0011064) | 1.68647039 |
137 | Stomatitis (HP:0010280) | 1.67918340 |
138 | Mitral regurgitation (HP:0001653) | 1.67855012 |
139 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.67747170 |
140 | Recurrent cutaneous fungal infections (HP:0011370) | 1.67747170 |
141 | Rib fusion (HP:0000902) | 1.67195615 |
142 | Micronodular cirrhosis (HP:0001413) | 1.67138032 |
143 | Thrombocytosis (HP:0001894) | 1.67132733 |
144 | Entropion (HP:0000621) | 1.66686383 |
145 | Precocious puberty (HP:0000826) | 1.66588017 |
146 | 11 pairs of ribs (HP:0000878) | 1.66493669 |
147 | Large earlobe (HP:0009748) | 1.64587131 |
148 | Sparse scalp hair (HP:0002209) | 1.64019997 |
149 | Proximal placement of thumb (HP:0009623) | 1.63901679 |
150 | Renovascular hypertension (HP:0100817) | 1.63742348 |
151 | Abnormality of the peritoneum (HP:0002585) | 1.62412910 |
152 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.62297186 |
153 | Short nail (HP:0001799) | 1.62274008 |
154 | Anal atresia (HP:0002023) | 1.62250148 |
155 | Hepatoblastoma (HP:0002884) | 1.61448394 |
156 | Ocular albinism (HP:0001107) | 1.61205053 |
157 | Cutis marmorata (HP:0000965) | 1.61169972 |
158 | Protrusio acetabuli (HP:0003179) | 1.61089089 |
159 | Abnormal number of erythroid precursors (HP:0012131) | 1.60616649 |
160 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.60478551 |
161 | Bowel incontinence (HP:0002607) | 1.60463458 |
162 | Insomnia (HP:0100785) | 1.60434365 |
163 | Thin bony cortex (HP:0002753) | 1.59714890 |
164 | Hypoplasia of the radius (HP:0002984) | 1.58713600 |
165 | Abnormality of the thoracic spine (HP:0100711) | 1.58418823 |
166 | Knee flexion contracture (HP:0006380) | 1.57959114 |
167 | Patellar dislocation (HP:0002999) | 1.55927272 |
168 | Metaphyseal cupping (HP:0003021) | 1.55544284 |
169 | Abnormality of the calcaneus (HP:0008364) | 1.55082875 |
170 | High anterior hairline (HP:0009890) | 1.54126942 |
171 | Renal cell carcinoma (HP:0005584) | 1.54011582 |
172 | Aneurysm (HP:0002617) | 1.53577614 |
173 | Abnormal tarsal ossification (HP:0008369) | 1.53462822 |
174 | Biconcave vertebral bodies (HP:0004586) | 1.52348136 |
175 | Termporal pattern (HP:0011008) | 1.51026275 |
176 | Insidious onset (HP:0003587) | 1.51026275 |
177 | Distal upper limb amyotrophy (HP:0007149) | 1.50663733 |
178 | Upper limb amyotrophy (HP:0009129) | 1.50663733 |
179 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.49764410 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TNIK | 5.94516188 |
2 | TRIB3 | 4.53086378 |
3 | MKNK2 | 3.89893066 |
4 | CDK12 | 3.72073273 |
5 | SMG1 | 3.55762453 |
6 | NLK | 3.23639299 |
7 | FES | 2.95046669 |
8 | FGFR4 | 2.84707386 |
9 | TLK1 | 2.66129117 |
10 | EIF2AK3 | 2.49741192 |
11 | MKNK1 | 2.47740309 |
12 | BRD4 | 1.90664483 |
13 | EEF2K | 1.89528276 |
14 | MUSK | 1.81130980 |
15 | SRPK1 | 1.76539726 |
16 | ERN1 | 1.73705938 |
17 | FLT3 | 1.63064772 |
18 | CDC7 | 1.61588779 |
19 | NEK2 | 1.59251073 |
20 | CDK7 | 1.51636643 |
21 | CSK | 1.46008016 |
22 | TEC | 1.45978347 |
23 | CLK1 | 1.45944831 |
24 | PDGFRA | 1.44211935 |
25 | KIT | 1.43920921 |
26 | CDK9 | 1.43583049 |
27 | CAMK1D | 1.42964270 |
28 | YES1 | 1.42600226 |
29 | RIPK1 | 1.40122343 |
30 | SCYL2 | 1.38443224 |
31 | WEE1 | 1.38026127 |
32 | TTN | 1.35831310 |
33 | EIF2AK2 | 1.34334664 |
34 | CDK4 | 1.32533385 |
35 | MAP4K1 | 1.29703609 |
36 | MAP3K10 | 1.26186950 |
37 | PRKD2 | 1.22510605 |
38 | PRPF4B | 1.20857198 |
39 | CDK6 | 1.18887106 |
40 | EPHA2 | 1.16954123 |
41 | PIM1 | 1.13026091 |
42 | CSF1R | 1.11222143 |
43 | DYRK3 | 1.08329855 |
44 | HIPK2 | 1.07072807 |
45 | PRKAA2 | 1.03280268 |
46 | ATR | 1.02032537 |
47 | MAP3K13 | 0.99526854 |
48 | ACVR1B | 0.98881098 |
49 | STK4 | 0.98089744 |
50 | MAP3K7 | 0.97761900 |
51 | CAMK1 | 0.96529332 |
52 | MELK | 0.95739740 |
53 | KSR2 | 0.95731527 |
54 | BTK | 0.93882862 |
55 | ZAK | 0.88422458 |
56 | CDC42BPA | 0.88133897 |
57 | RET | 0.87487587 |
58 | FER | 0.87124260 |
59 | HCK | 0.86275360 |
60 | RPS6KB2 | 0.86049352 |
61 | FGFR3 | 0.85802754 |
62 | MAP2K3 | 0.85054030 |
63 | ATM | 0.84895943 |
64 | CAMK1G | 0.84864065 |
65 | TYRO3 | 0.84644867 |
66 | DYRK1B | 0.83715800 |
67 | TGFBR2 | 0.83168322 |
68 | PTK6 | 0.81857822 |
69 | SGK3 | 0.80329783 |
70 | TXK | 0.79401682 |
71 | LATS1 | 0.77843687 |
72 | LCK | 0.76981571 |
73 | CHEK2 | 0.76379736 |
74 | AKT3 | 0.74288142 |
75 | FGFR2 | 0.73109124 |
76 | MTOR | 0.71321763 |
77 | MAPK11 | 0.69894481 |
78 | WNK1 | 0.69293770 |
79 | CAMK4 | 0.68566573 |
80 | LATS2 | 0.67881128 |
81 | LYN | 0.67551980 |
82 | MST1R | 0.66487219 |
83 | MATK | 0.64867221 |
84 | ICK | 0.64339249 |
85 | RIPK4 | 0.64154971 |
86 | MAP3K2 | 0.63431082 |
87 | MAP3K8 | 0.61309027 |
88 | SIK2 | 0.61234913 |
89 | AURKB | 0.60884035 |
90 | PDGFRB | 0.60702946 |
91 | EPHB1 | 0.60650866 |
92 | IRAK4 | 0.60309440 |
93 | MAP3K1 | 0.59525580 |
94 | CHEK1 | 0.59521420 |
95 | TAOK1 | 0.59133459 |
96 | STK10 | 0.57795644 |
97 | RPS6KC1 | 0.56522521 |
98 | RPS6KL1 | 0.56522521 |
99 | PKN2 | 0.56368990 |
100 | MAPK4 | 0.55816665 |
101 | TRPM7 | 0.55649662 |
102 | DMPK | 0.54198997 |
103 | PDPK1 | 0.54045631 |
104 | MAP3K14 | 0.53946533 |
105 | IKBKB | 0.51843544 |
106 | PRKDC | 0.51220699 |
107 | CDK2 | 0.51186351 |
108 | RPS6KA2 | 0.50732935 |
109 | SIK1 | 0.50629517 |
110 | MAPK10 | 0.50234054 |
111 | FGFR1 | 0.49364073 |
112 | PASK | 0.49060868 |
113 | CAMKK2 | 0.48591745 |
114 | PAK4 | 0.48244961 |
115 | PTK2 | 0.48026745 |
116 | PLK1 | 0.47961414 |
117 | IRAK3 | 0.47286195 |
118 | CASK | 0.46932474 |
119 | NEK6 | 0.46690830 |
120 | JAK3 | 0.45748100 |
121 | MAP3K3 | 0.45440865 |
122 | MAPK14 | 0.45126705 |
123 | RPS6KA6 | 0.44765043 |
124 | IRAK2 | 0.43749960 |
125 | CHUK | 0.42870864 |
126 | BMX | 0.41898056 |
127 | TGFBR1 | 0.41459617 |
128 | TYK2 | 0.40769802 |
129 | NUAK1 | 0.40624069 |
130 | JAK1 | 0.40595721 |
131 | SIK3 | 0.40484231 |
132 | NEK9 | 0.40224831 |
133 | CSNK1D | 0.40031037 |
134 | PAK2 | 0.39948159 |
135 | MARK2 | 0.39936304 |
136 | PDK1 | 0.39010994 |
137 | ZAP70 | 0.38650297 |
138 | CSNK1G1 | 0.38361851 |
139 | AKT1 | 0.37867980 |
140 | TTK | 0.37849763 |
141 | RPS6KB1 | 0.37090842 |
142 | MAP3K6 | 0.36753670 |
143 | PRKAA1 | 0.36624592 |
144 | MAPK1 | 0.35713050 |
145 | PRKD3 | 0.35684667 |
146 | RPS6KA5 | 0.35571955 |
147 | ALK | 0.35461927 |
148 | RPS6KA1 | 0.34935130 |
149 | TNK2 | 0.34282262 |
150 | * GSK3B | 0.34056785 |
151 | * CDK1 | 0.33795766 |
152 | MAPK7 | 0.32993390 |
153 | GRK6 | 0.31953239 |
154 | ABL1 | 0.31785648 |
Rank | Gene Set | Z-score |
---|---|---|
1 | DNA replication_Homo sapiens_hsa03030 | 3.24037873 |
2 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.41649591 |
3 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.37118110 |
4 | Homologous recombination_Homo sapiens_hsa03440 | 2.32553166 |
5 | Mismatch repair_Homo sapiens_hsa03430 | 2.26304946 |
6 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 2.25346388 |
7 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 2.21989134 |
8 | Base excision repair_Homo sapiens_hsa03410 | 2.19328313 |
9 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.12285215 |
10 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.09001943 |
11 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.00785476 |
12 | Spliceosome_Homo sapiens_hsa03040 | 1.92456963 |
13 | Thyroid cancer_Homo sapiens_hsa05216 | 1.90841205 |
14 | Lysine degradation_Homo sapiens_hsa00310 | 1.87230204 |
15 | Ribosome_Homo sapiens_hsa03010 | 1.67109228 |
16 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.62020815 |
17 | Cell cycle_Homo sapiens_hsa04110 | 1.54370587 |
18 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.52488514 |
19 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.46622718 |
20 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.46255836 |
21 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.45604762 |
22 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.43565210 |
23 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.39745846 |
24 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.34560051 |
25 | Glioma_Homo sapiens_hsa05214 | 1.34532395 |
26 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.33236645 |
27 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.32398769 |
28 | Bladder cancer_Homo sapiens_hsa05219 | 1.29804402 |
29 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.28978439 |
30 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.28205013 |
31 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.27999126 |
32 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.27189608 |
33 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.26037586 |
34 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.25885047 |
35 | Phototransduction_Homo sapiens_hsa04744 | 1.25607364 |
36 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.22853412 |
37 | Measles_Homo sapiens_hsa05162 | 1.22579760 |
38 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.20934111 |
39 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.18935881 |
40 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.18463352 |
41 | RNA transport_Homo sapiens_hsa03013 | 1.17184029 |
42 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.16936660 |
43 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.12047776 |
44 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.10872969 |
45 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.09261136 |
46 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.06527524 |
47 | Insulin resistance_Homo sapiens_hsa04931 | 1.03943803 |
48 | Wnt signaling pathway_Homo sapiens_hsa04310 | 1.02959460 |
49 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.02832631 |
50 | Alcoholism_Homo sapiens_hsa05034 | 1.02155719 |
51 | Basal transcription factors_Homo sapiens_hsa03022 | 1.00588515 |
52 | HTLV-I infection_Homo sapiens_hsa05166 | 0.99806896 |
53 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.98379371 |
54 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.97917057 |
55 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.97469266 |
56 | Hepatitis C_Homo sapiens_hsa05160 | 0.96713468 |
57 | Hepatitis B_Homo sapiens_hsa05161 | 0.95691357 |
58 | Sulfur relay system_Homo sapiens_hsa04122 | 0.93184930 |
59 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.92937643 |
60 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.91853404 |
61 | Prostate cancer_Homo sapiens_hsa05215 | 0.91172572 |
62 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.90125996 |
63 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.88505528 |
64 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.87320364 |
65 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.86432839 |
66 | RNA degradation_Homo sapiens_hsa03018 | 0.86317532 |
67 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.83225178 |
68 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.81781968 |
69 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.81345113 |
70 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.79444895 |
71 | Adherens junction_Homo sapiens_hsa04520 | 0.79211101 |
72 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.77782748 |
73 | Pathways in cancer_Homo sapiens_hsa05200 | 0.77492240 |
74 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.76821473 |
75 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.76711308 |
76 | Colorectal cancer_Homo sapiens_hsa05210 | 0.76695947 |
77 | Malaria_Homo sapiens_hsa05144 | 0.76390355 |
78 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.73507724 |
79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.72274086 |
80 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.71864907 |
81 | Leishmaniasis_Homo sapiens_hsa05140 | 0.71430361 |
82 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.71003207 |
83 | Platelet activation_Homo sapiens_hsa04611 | 0.70205405 |
84 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.69172811 |
85 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.69025858 |
86 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.67847305 |
87 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.67722702 |
88 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.67329043 |
89 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.65761258 |
90 | ABC transporters_Homo sapiens_hsa02010 | 0.65446331 |
91 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.65269017 |
92 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.64216393 |
93 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.63307948 |
94 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.62351814 |
95 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.62268742 |
96 | Long-term potentiation_Homo sapiens_hsa04720 | 0.61673658 |
97 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.61477951 |
98 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.61332726 |
99 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.61165564 |
100 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.59818120 |
101 | Influenza A_Homo sapiens_hsa05164 | 0.59652458 |
102 | Viral myocarditis_Homo sapiens_hsa05416 | 0.58335829 |
103 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.58132934 |
104 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.57807224 |
105 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.54756225 |
106 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.54687548 |
107 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.54568791 |
108 | Endometrial cancer_Homo sapiens_hsa05213 | 0.54330891 |
109 | Endocytosis_Homo sapiens_hsa04144 | 0.53499568 |
110 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.53221184 |
111 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.52871641 |
112 | Amoebiasis_Homo sapiens_hsa05146 | 0.52248929 |
113 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.52193510 |
114 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.52019850 |
115 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.52016145 |
116 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.51120004 |
117 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.50815795 |
118 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.50447450 |
119 | Tight junction_Homo sapiens_hsa04530 | 0.49544391 |
120 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.49042184 |
121 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.48492023 |
122 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.48184488 |
123 | Prion diseases_Homo sapiens_hsa05020 | 0.48155518 |
124 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.47669839 |
125 | Other glycan degradation_Homo sapiens_hsa00511 | 0.43103943 |
126 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.42452264 |
127 | Melanoma_Homo sapiens_hsa05218 | 0.42019440 |
128 | Apoptosis_Homo sapiens_hsa04210 | 0.41806361 |
129 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.40649742 |
130 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.40486133 |
131 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.40406746 |
132 | Focal adhesion_Homo sapiens_hsa04510 | 0.40263943 |
133 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.39939095 |
134 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.38741710 |
135 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.38598291 |
136 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.38569728 |
137 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.38139267 |
138 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.37184525 |